Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/12/2013 | CN103142637A Capsule containing colloidal bismuth pectin |
06/12/2013 | CN103142636A Black fungus polysaccharide and grape pip procyanidine composite antioxidant capsule |
06/12/2013 | CN103142635A Application of laminarin in preparation of medicaments or cosmetics for adjusting metabolism of collagen of skin |
06/12/2013 | CN103142634A Spirulina phatensis polysaccharide and cynomorium songaricum polysaccharide preparation and manufacture method thereof and application thereof |
06/12/2013 | CN103142633A Compound amino acid capsule including eight amino acids and eleven vitamins |
06/12/2013 | CN103142632A Macrolides and uses of macrolides |
06/12/2013 | CN103142631A Application of traditional Chinese medicine composition as antidepressant drug |
06/12/2013 | CN103142630A Application of hesperidin or derivatives thereof as antidepressant drug |
06/12/2013 | CN103142629A Application of neohesperidin as antidepressant drug |
06/12/2013 | CN103142628A Application of diterpenoid compound in treating hepatitis c virus (HCV) |
06/12/2013 | CN103142627A Application of triacetyl glucal in preparation of antiviral drug |
06/12/2013 | CN103142626A Application of triacetyl glucal in preparation of antitumor drug |
06/12/2013 | CN103142625A Fosfomycin sodium pharmaceutical composition and preparation method thereof |
06/12/2013 | CN103142624A Application of antibiotic tigecycline in preparing anti-cancer medicine |
06/12/2013 | CN103142623A Calcitriol and strontium ranelate suspension granule and preparation method thereof |
06/12/2013 | CN103142622A Triamcinolone acetonide and miconazole emulsion type gel |
06/12/2013 | CN103142621A Medical applications of four buxus alkaloids compounds |
06/12/2013 | CN103142620A Application of ursolic acid to antitumor immunity |
06/12/2013 | CN103142619A Pharmaceutical composition for treating dermatitis and preparation method thereof |
06/12/2013 | CN103142618A Metroprolol succinate hydrochlorothiazide sustained-release pellet capsule and preparation method thereof |
06/12/2013 | CN103142617A Cefuroxime lysine medicinal composition |
06/12/2013 | CN103142616A Pharmaceutical composition for improving pharmaceutical stability |
06/12/2013 | CN103142615A Ceftriaxone sodium pharmaceutical composition and preparation method thereof |
06/12/2013 | CN103142614A Pharmacy application of composite product |
06/12/2013 | CN103142613A Application of drug composition |
06/12/2013 | CN103142612A Medical application of composite |
06/12/2013 | CN103142611A Pharmacy application of composite product in treating bacterium infection |
06/12/2013 | CN103142610A Pharmacy application of composite product |
06/12/2013 | CN103142609A Application of drug composition product |
06/12/2013 | CN103142608A Codeine phosphate and promethazine hydrochloride compound membranous preparation |
06/12/2013 | CN103142607A Preparation method of tegafur gimeracil oteracil potassium capsule |
06/12/2013 | CN103142606A Paracetamol and caffeine enteric tablet and preparation method thereof |
06/12/2013 | CN103142605B Novel use of doxofylline compound |
06/12/2013 | CN103142605A Novel use of doxofylline compound |
06/12/2013 | CN103142604A Acetaminophen and caffeine dispersible tablet, and its preparation method |
06/12/2013 | CN103142603A Isoguanine compound used for treating hepatitis C virus (HCV) |
06/12/2013 | CN103142602A Application of allopurinol in preparing medicines after atrial fibrillation catheter ablation |
06/12/2013 | CN103142601A Application of PCI (Percutaneous Coronary Intervention)-32765 for preparing anti-angiogenic medicines |
06/12/2013 | CN103142600A Weekly administration of dipeptidyl peptidase inhibitors |
06/12/2013 | CN103142599A Treatment of T-cell mediated diseases |
06/12/2013 | CN103142598A Application of liriodendrin in preparing medicine for resisting meticillin-resistant staphylococcus aureus (MRSA) |
06/12/2013 | CN103142597A Ipecacuanha effective component composition, its preparation method and application |
06/12/2013 | CN103142596A Medicinal composition containing telmisartan and pitavastatin |
06/12/2013 | CN103142595A Quinoline derivatives for treatment of latent tuberculosis |
06/12/2013 | CN103142594A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
06/12/2013 | CN103142593A Application of neurokinin receptor 2 antagonist to treatment of leukemia |
06/12/2013 | CN103142592A Medicine for preventing fish saprolegniasis and application thereof |
06/12/2013 | CN103142591A Ticarcillin sodium-potassium clavulanate pharmaceutical composition powder injection |
06/12/2013 | CN103142590A Ampicillin sodium-cloxacillin sodium pharmaceutical composition and preparation method thereof |
06/12/2013 | CN103142589A Mezlocillin sodium pharmaceutical composition for injection and preparation method thereof |
06/12/2013 | CN103142588A Amoxicillin sodium sulbactam sodium for injection and preparation method of amoxicillin sodium sulbactam sodium |
06/12/2013 | CN103142587A Amoxicillin sodium-potassium clavulanate pharmaceutical composition and preparation method thereof |
06/12/2013 | CN103142586A 治疗疾病的疗法 Treatment of disease therapy |
06/12/2013 | CN103142585A Antifungal acne cream |
06/12/2013 | CN103142584A Application of polysubstituted 5-hydroxypyrrolidone compounds in preparation of antitumor medicines |
06/12/2013 | CN103142583A Levetiracetam-containing pharmaceutical composition and preparation method thereof |
06/12/2013 | CN103142582A Application of flavone compound in preparation of medicines for preventing or treating tumors |
06/12/2013 | CN103142581A Application of natural compound luteolin in anti-hepatitis B virus |
06/12/2013 | CN103142580A Application of barbaloin |
06/12/2013 | CN103142579A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142578A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142577A Salvianolic acid A composition and application thereof to medicine preparation |
06/12/2013 | CN103142576A Application of salvianolic acid A freeze-dried powder to preparation of drug for protecting cerebral vascular endothelial cells |
06/12/2013 | CN103142575A Application of salvianolic acid A freeze-dried powder to preparation of drug for inhibiting neuronal damage or death of brain tissue |
06/12/2013 | CN103142574A Salvianolic acid A freeze-dried powder and application thereof to medicine preparation |
06/12/2013 | CN103142573A Application of salvianolic acid A freeze-dried powder to preparation of drug for improving symptom of neurological function after cerebral ischemia |
06/12/2013 | CN103142572A Salvianolic acid A tablet and application thereof to medicine preparation |
06/12/2013 | CN103142571A Salvianolic acid A composition and application thereof to medicine preparation |
06/12/2013 | CN103142570A Use of low-dose Ladostigil for neuroprotection |
06/12/2013 | CN103142569A 2, 6-diisopropyl benzoic acid and application of 2, 6-diisopropyl benzoic acid derivative serving as neuroprotective agent |
06/12/2013 | CN103142568A Calcium acetate-vitamin K pharmaceutical preparation and preparation method thereof |
06/12/2013 | CN103142567A Softening and dissolving method of ossific mass |
06/12/2013 | CN103142566A Important-protein inhibitor in severe fever with thrombocytopenia syndrome |
06/12/2013 | CN103142565A Novel nimesulide sustained-release pharmaceutical composition and preparation method thereof |
06/12/2013 | CN103142564A Pharmaceutical composition for treating tinea pedis and preparation method thereof |
06/12/2013 | CN103142563A Application of Mucosolvan in preparing product for cleaning depleted uranium particles in lung |
06/12/2013 | CN103142562A Sustained-release sticking film for treating oral ulcer |
06/12/2013 | CN103142560A Montelukast sodium film-like preparation |
06/12/2013 | CN103142559A Risperidone film-like preparation |
06/12/2013 | CN103142558A Diclofenac sodium dual-release enteric-coated preparation, as well as preparation method and control method thereof |
06/12/2013 | CN103142557A Polymannuronate sulfate slow release capsule and preparation method thereof |
06/12/2013 | CN103142556A Polysaccharide sulfate sustained-release capsule and preparation method thereof |
06/12/2013 | CN103142555A Alfacalcidol sustained-release capsule and preparation method thereof |
06/12/2013 | CN103142554A Calcitriol controlled-release capsule and preparation method thereof |
06/12/2013 | CN103142553A Calcitriol sustained-release capsule and preparation method thereof |
06/12/2013 | CN103142552A Lovastatin enteric coated sustained-release pellet capsule and preparation method thereof |
06/12/2013 | CN103142549A Mannose ester enteric capsule and preparation method thereof |
06/12/2013 | CN103142548A Colloidal bismuth pectin capsule |
06/12/2013 | CN103142547A Calcitriol enteric capsule and preparation method thereof |
06/12/2013 | CN103142546A Calcitriol capsule and preparation method thereof |
06/12/2013 | CN103142545A Enteric capsule of etoposide |
06/12/2013 | CN103142544A Ubenimex capsule composition and preparation method thereof |
06/12/2013 | CN103142543A Salvianolic acid A capsule and application thereof to medicine preparation |
06/12/2013 | CN103142542A Salvianolic acid A capsule and application thereof to medicine preparation |
06/12/2013 | CN103142541A Stable montelukast sodium capsule |
06/12/2013 | CN103142540A PGMS (Propylene Glycol Mannate Sulfate) controlled-release tablet and preparation method thereof |
06/12/2013 | CN103142539A Alginic sodium diester controlled-release tablet and preparation method thereof |
06/12/2013 | CN103142538A PGMS (Propylene Glycol Mannate Sulfate) enteric tablet and preparation method thereof |
06/12/2013 | CN103142537A Calcitriol slow-release preparation troche |
06/12/2013 | CN103142536A Calcitriol enteric tablet and preparation method thereof |